K151809 is an FDA 510(k) clearance for the Alere Afinion HbA1c, Alere Afinion AS100 Analyzer. Classified as Assay, Glycosylated Hemoglobin (product code LCP), Class II - Special Controls.
Submitted by Alere Technologies AS (Oslo, NO). The FDA issued a Cleared decision on September 25, 2015 after a review of 85 days - a notably fast clearance cycle.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 864.7470 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.